Tumor derived interleukin-6 increases hepatic thrombopoietin, which stimulates bone marrow megakaryocytes and platelet production of TGF-β1, which in turn activates the TGF-β1/smad proliferation pathway in tumor cells [7]. The gene discussed is IL6; the disease is neoplasm.